BEST of ASCO Portugal 2024 - IG: BEST of ASCO Portugal 2024
The treatment of lung cancer has evolved significantly in recent years, mainly due to the development of immunotherapy and molecular-targeted therapies. As with advanced disease, important advances have also been made in localized disease, which have resulted in changes in the treatment paradigm in this disease context. This article analyzes the main studies presented at the 2024 annual congress of the American Society of Clinical Oncology in the field of localized lung cancer and mesothelioma.
Publication Details
- Journal
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
- Published
- 2024-11-26
- Primary Topic
- Occupational and environmental lung diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00